3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Bronchogenic
1
Interventions
Cyclophosphamide
4
Flow Cytometry
3
Surveys and Questionnaires
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methylprednisolone
2
Methods
2
Melphalan
2
Immunologic Techniques
2
Filgrastim
2
Data Collection
2
Blood Specimen Collection
2
Azacitidine
2
Alemtuzumab
2
tanespimycin
1
sargramostim
1
ruxolitinib
1
rucaparib
1
ribociclib
1
pembrolizumab
1
motexafin gadolinium
1
liposomal doxorubicin
1
fludarabine phosphate
1
flt3 ligand protein
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
cc-486
1
bosutinib
1
aldesleukin
1
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Interleukin-15
×
Breast
×
Clear all
NCT07410676
2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2
Recruiting
83 enrolled